Squarepoint
INSM icon

Squarepoint’s Insmed INSM Stock Holding History

Squarepoint’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41M Buy
+8,600
New +$1.32M ﹤0.01% 2471
2025
Q4 		– Sell
-45,500
Closed -$6.55M – 4555
2025
Q3 		$6.55M Hold
45,500
– – 0.01% 1306
2025
Q2 		$4.58M Buy
+45,500
New +$3.48M ﹤0.01% 1518

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Squarepoint's INSM Position: Q1 2026 in Review

Squarepoint reduced its Insmed (INSM) stake by 41% in Q1 2026, selling an estimated $4.16M and leaving 39,316 shares worth $6.43M. The position accounts for 0.01% of the portfolio, ranked #1328.

Squarepoint first reported a position in INSM in Q4 2015 and has held it in 26 quarters since. The position peaked at $35.5M in Q3 2024. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Squarepoint held 39,316 shares of Insmed worth $6.43M as of Q1 2026.
  • Squarepoint sold 27,086 Insmed shares in Q1 2026, an estimated $4.16M.
  • Insmed made up 0.01% of Squarepoint's portfolio in Q1 2026, its #1328 holding.
  • Squarepoint first reported a position in Insmed in Q4 2015 and has held it in 26 quarters since.
  • Squarepoint's Insmed position peaked at $35.5M in Q3 2024.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.